Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Ifeyinwa (ify) Osunkwo, MD MPH, Padmaja Veeramreddy, MD, Justin Arnall, PharmD, CPP, BCOP, Rachel Crawford, PharmD, BCPS, James T Symanowski, PhD, Rasaq Olaosebikan, MD MSc, Srinivasa Reddy Sanikommu, MD, Stephanie Newby, MD, Stephen Wyatt, DO, Jamie Sebaaly, Katherine Rector

Blood (2019) 134 (Supplement_1): 790.

https://doi.org/10.1182/blood-2019-126589

Published: 2019

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Richard Onalo, FCPaed, Peter Cooper, FCPaed, Antoinette Cilliers, FCPaed, Uche Nnebe-Agumadu, FCPaed, Oluseyi Oniyangi, FCPaed, Damilare Oladimeji, MSc Statistics, Claudia R. Morris, MD

Blood (2019) 134 (Supplement_1): 613.

https://doi.org/10.1182/blood-2019-122510

Published: 2019

Journal Articles

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Ashley Thrower, BS, Zhou Laura, Vimal K. Derebail, MD, David Wichlan, Ashley Smith, RN, Jianwen Cai, PhD, Kenneth I. Ataga, MD

Blood (2019) 134 (Supplement_1): 2308.

https://doi.org/10.1182/blood-2019-131368

Published: 2019

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up

Matthew Danish, MD MS, Tabitha Copeland, MD, Joseph Ho, MD, Mansi Shah, MD BA, Dennis Cooper, MD

Blood (2019) 134 (Supplement_1): 4726.

https://doi.org/10.1182/blood-2019-131551

Published: 2019

Journal Articles

The Impact of a Mandatory Prescription Drug Monitoring Program (PDMP) on Opioid Prescription Among Sickle Cell Disease Patients By Emergency Medicine Physicians in Community Teaching Hospitals in Philadelphia

Sufana Shikdar, MD MPH, Vinay Edlukudige Edlukudige Keshava, MBBS, Peter Lambert, MD, Sindusha Gudipally, MD, Anthony Esposito, Brad Bendesky, MD, Eric Green, MDMSc

Blood (2019) 134 (Supplement_1): 4703.

https://doi.org/10.1182/blood-2019-122394

Published: 2019

Journal Articles

L-Glutamine Decreases Opioid Use in Individuals with Sickle Cell Disease and Chronic Pain: A Case Series

Samuel Wilson, MD, Frances Wright, CPNP, Marcus A. Carden, MD

Blood (2019) 134 (Supplement_1): 4849.

https://doi.org/10.1182/blood-2019-126179

Published: 2019

Journal Articles

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Claudia R. Morris, MD, Janet Figueroa, MPH, Amanda Watt, Kirshma Khemani, MD, Polly Kumari, MBBS, Morgan Barnett, MPH, Nitya Bakshi, MBBS, MS, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 995.

https://doi.org/10.1182/blood-2019-122983

Published: 2019

Journal Articles

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Nadirah El-Amin, MPH, DO, Paul Nietert, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2018-99-117206

Published: 2018

Journal Articles

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

Aditya M Mittal, Huy Tran, BSMedTech, Varun Sagi, BS, Aithanh Nguyen, Kathryn Luk, Julia Nguyen, BS, Jianxun Lei, PhD, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 269.

https://doi.org/10.1182/blood-2018-99-117246

Published: 2018

Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Ryan D. Cassaday, MD, Lorinda A. Soma, MD, Olga Sala-Torra, MD, Philip A. Stevenson, MS, Mary-Elizabeth M. Percival, MD, Vivian G. Oehler, MD, Andrei R. Shustov, MD, Pamela S. Becker, MD, Anna B. Halpern, MD, Kelsey-Leigh Garcia, Christen N. Heye, ARNP, Jerald P. Radich, MD, Elihu H. Estey, MD

Blood (2018) 132 (Supplement 1): 1419.

https://doi.org/10.1182/blood-2018-99-110661

Published: 2018

Journal Articles

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Madiha Iqbal, MBBS, Aaron C. Spaulding, Chanel Wood, Salman Ahmed, MD, Prachi Jani, MD, Rami Manochakian, MD, Aneel Paulus, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD, Sikander Ailawadhi, Asher A. Chanan-Khan, MD, Shehzad Niazi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4852.

https://doi.org/10.1182/blood-2018-99-119912

Published: 2018

Journal Articles

Real World Experience with Sublingual Fentanyl for the Treatment of Sickle Cell Vaso-Occlusive Episodes in Adults in a Tertiary Canadian Emergency Department

Hayley Merkeley, MD, Sam Sabbah, MBBS, MSc, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc,FRCPC

Blood (2018) 132 (Supplement 1): 5879.

https://doi.org/10.1182/blood-2018-99-116676

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Brian Pennarola, MD, Patrick Demartino, MD, Dale W. Steele, MD, Susan J. Duffy, MD

Blood (2018) 132 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2018-99-117703

Published: 2018

Journal Articles

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Madiha Iqbal, MBBS, Aaron C. Spaulding, Salman Ahmed, MD, Prachi Jani, MD, Chanel Wood, Shehzad Niazi, Rami Manochakian, MD, Aneel Paulus, MD, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Vivek Roy, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 5873.

https://doi.org/10.1182/blood-2018-99-119781

Published: 2018

Journal Articles

Effect of Chronic Opioid Therapy on Pain and Survival in a Mouse Model of Sickle Cell Disease

Varun Sagi, BS, Huy Tran, BSMedTech, Waogwende Leonce Song-Naba, BS, Ying WANG, PhD, Aditya M Mittal, Yann Lamarre, PhD, Lei Zhang, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 726.

https://doi.org/10.1182/blood-2018-99-111871

Published: 2018

Journal Articles

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Mandy David, PA-C, MPH, Christopher Carroll, MD, Ashley Lauriello, NP, Benjamin Salzberg, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 856.

https://doi.org/10.1182/blood-2018-99-111435

Published: 2018

Journal Articles

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Camila Albo, Sanjiv Kumar, PhD, Michael Pope, Bachelors/MDcal Student, Kyle Michael Kidwell, Bachelors/MDcal Student, Niren Patel, MBBS, Leigh Wells, MSN, Latanya Bowman, RN, Nadine Barrett, MSN, Xu Hongyan, PhD, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 857.

https://doi.org/10.1182/blood-2018-99-115084

Published: 2018

NARROW

Use of Buprenorphine/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Oral Arginine Therapy As a Novel Adjuvant in the Management of Acute Pain in Children with Sickle Cell Anemia in Nigeria: A Randomized Placebo-Controlled Trial

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up

The Impact of a Mandatory Prescription Drug Monitoring Program (PDMP) on Opioid Prescription Among Sickle Cell Disease Patients By Emergency Medicine Physicians in Community Teaching Hospitals in Philadelphia

L-Glutamine Decreases Opioid Use in Individuals with Sickle Cell Disease and Chronic Pain: A Case Series

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Real World Experience with Sublingual Fentanyl for the Treatment of Sickle Cell Vaso-Occlusive Episodes in Adults in a Tertiary Canadian Emergency Department

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Effect of Chronic Opioid Therapy on Pain and Survival in a Mouse Model of Sickle Cell Disease

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only